Stealth PEG-PHDCA niosomes: Effects of Chain Length of PEG and Particle Size on Niosomes Surface Properties, In Vitro Drug Release, Phagocytic Uptake, In Vivo Pharmacokinetics and Antitumor Activity
- 1 September 2006
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 95 (9), 1873-1887
- https://doi.org/10.1002/jps.20491
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Studies on a high encapsulation of colchicine by a niosome systemInternational Journal of Pharmaceutics, 2002
- Camptothecin Delivery MethodsPharmaceutical Research, 2002
- PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriersJournal of Controlled Release, 2001
- Stealth Polycyanoacrylate Nanoparticles as Tumor Necrosis Factor-.ALPHA. Carriers: Pharmacokinetics and Anti-tumor Effects.Biological & Pharmaceutical Bulletin, 2001
- Visualization of in vitro protein-rejecting properties of PEGylated stealth® polycyanoacrylate nanoparticlesBiomaterials, 1999
- Non-ionic surfactant based vesicles (niosomes) in drug deliveryInternational Journal of Pharmaceutics, 1998
- Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticlesLife Sciences, 1997
- Synthesis of a Novel Poly(MePEG cyanoacrylate-co-alkyl cyanoacrylate) Amphiphilic Copolymer for Nanoparticle TechnologyMacromolecules, 1997
- Reversed-phase high-performance liquid chromatography method for the simultaneous quantitation of the lactone and carboxylate forms of the novel natural product anticancer agent 10-hydroxycamptothecin in biological fluids and tissuesJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- The Activity of Doxorubicin Niosomes Against an Ovarian Cancer Cell Line and Threein VivoMouse Tumour ModelsJournal of Drug Targeting, 1996